Holly Taylor was diagnosed with stage three ovarian cancer after selling her last company. Her rare form usually gets caught at stage one—99% survivable. Stage three? Different story. That personal experience drives everything she does at Lucem Health, where she's general manager of strategic partnerships focused on early disease detection using AI to find patterns in patient data before symptoms even start. Cervical cancer went from deadly to 99% survivable once pap smears became norma...